Document is current

Article History

Received: 16 February 2022

Accepted: 13 July 2022

First Online: 8 August 2022

Declarations

:

: This study is based on a study that was approved by the Ethics Committee for Health Research of Burkina Faso (CERS) (Ref. N°2017-1026/MS/RCEN/DRSC). It was approved by the Institutional Ethics Committee of Saint Camille Hospital of Ouagadougou (HOSCO)/Biomolecular Research Center Pietro Annigoni (CERBA) as necessary administrative permissions to access the raw data/samples mentioned in the methods. This study does not involve any risk to the health, physical and moral integrity of the participants. The clinical samples were obtained for the present study and the participants were patients received at the HOSCO bacteriology laboratory for routine examinations (vaginal swabs). Informed consent was obtained from all participants prior to data collection and all methods were carried out in accordance with relevant guidelines and regulations. The sample was then kept anonymous before use. In addition, they have already received their test results and we used the same samples to characterize the antibiotic resistance gene by PCR in order to contribute to their better management.

: Not applicable.

: Standard descriptive analysis was performed using Excel 2016 and IBM SPSS 25.0 (SPSS Inc., Illinois, USA) software. The χ² test and Fisher’s exact test was used to compare categorical variables and the differences between groups were considered statistically significant for p ≤ 0.05.

: The authors declare that they have no competing interests.